Back to Home
On-Demand Webinar

Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

Release Date

September 10, 2021

Expiration Date

September 10, 2022

Credits

1 On-Demand

Topics

Immunization, Infectious Disease

Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

On-Demand 1.0 hour Accredited Webcast
 
This activity is supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP.

Faculty Presenter

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey

Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
 


Program Description
COVID-19 continues to be a global threat with limited treatment options. An effective vaccine has the potential to reduce the spread and associated mortality related to this virus. A COVID-19 vaccine development initiative is underway and is rapidly evolving as ongoing clinical trials provide insight into vaccine candidate safety and efficacy. Pharmacists should have a comprehensive knowledge of COVID-19 vaccines to effectively educate the public and address concerns. This webinar will provide pharmacists with an update on current development efforts for a COVID-19 vaccine.

Target Audience: Retail pharmacist
Type of Activity: Application
Release date: September 10, 2021
Expiration date: September 10, 2022
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:
  • Examine updates related to the public health burden of COVID-19
  • Explore the currently available vaccines as well as the vaccines in development including updates related to clinical trial data
  • Explain the role of the pharmacist in addressing patients concerns revolving around the COVID-19 vaccinations
     
acpePharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-327-H06-P. The activity is available for CE credit through September 10, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

Disclosures

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FNAP, has the following relevant financial relationships with commercial interests to disclose:

Speakers Bureau: AstraZeneca

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD CHCP; Liz Rauh; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

The content of this activity may include information regarding the use of products that may be inconsistent with, or outside the approved labeling for, these products in the United States. Pharmacists should note that the use of these products outside current approved labeling is considered experimental and are advised to consult the prescribing information for these products.

Information contained in this activity is known to be accurate at the time of presentation. As this content continues to evolve, if viewing this presentation at a later time, content may not reflect current best practice or guidance. Participant is encouraged to seek out most updated guidance from the U.S. Centers for Disease Control and Prevention and U.S. Food and Drug Administration.

Activity Disclaimer
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this live CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
 
Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

Supporter statement here

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Follow Us on Social Media!

Related Content

Course

Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

Create Account